BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7901190)

  • 1. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
    Suzuki T; Takano Y
    Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis.
    de Rosa I; Staibano S; Lo Muzio L; Delfino M; Lucariello A; Coppola A; De Rosa G; Scully C
    J Oral Pathol Med; 1999 Jul; 28(6):252-8. PubMed ID: 10426197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
    Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas.
    Yue L; Iwai M; Furuta I
    Oral Oncol; 1999 Jan; 35(1):70-6. PubMed ID: 10211313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
    Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
    Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
    Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
    Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
    Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
    J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors.
    Oyama T; Osaki T; Mitsudomi T; Ogawa R; Nakanishi R; Sugio K; Yasumoto K
    Int J Mol Med; 1998 May; 1(5):823-6. PubMed ID: 9852302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
    Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
    J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.